“We know there are people who are interested in addressing their weight but have been waiting on the sidelines for a medicine that was right for them. For many of them, that wait is over as we can now offer the powerful efficacy of Wegovy in a once-daily pill that demonstrated about 17% weight loss, if all patients stayed on treatment,” stated Ed Cinca, senior vice president, Marketing & Patient Solutions at Novo Nordisk.

Related article

Exclusive interview: Jens Juul Holst

His is not a household name, but the drugs developed thanks to Danish scientist Jens Juul Holst’s research certainly are.